Since EZH2 inhibition was observed to have a significant inhibitory effect on the expression of CD155, we speculated that this phenomenon may have an additional effect on the anti-MM cell process of NK cells involved in the TIGIT-blocking monoclonal antibody. The gene discussed is TIGIT; the disease is Miyoshi myopathy.